Open access · CC-BY
via OpenAlex
Cellular senescence in the tumor with a bone niche microenvironment: friend or foe?
Sajad Alavimanesh, Negar Nayerain Jazi, Maedeh Choubani, Farzane Saeidi, Hamed Afkhami, Aref Yarahmadi, Hossein Ronaghi, Pouria Khani, Mohammad Hossein Modarressi
Clinical and Experimental Medicine · 2025 · ▲ 15 citations
Abstract
Cellular senescence(definition) is understood to be a biological process that is defined as irreversible growth arrest and was originally recognized as a tumor-suppressive mechanism that prevents further propagation of damaged cells. More recently, cellular senescence has been shown to have a dual role in prevention and tumor promotion. Senescent cells carry a senescence-associated secretory phenotype (SASP), which is altered by secretory factors including pro-inflammatory cytokines, chemokines, and other proteases, leading to the alteration of the tissue microenvironment. Though senescence would eventually halt the growth of cancerous potential cells, SASP contributes to the tumor environment by promoting inflammation, matrix remodeling, and tumor cell invasion. The paradox of tumor prevention/promotion is particularly relevant to the bone niche tumor microenvironment, where longer-lasting, chronic inflammation promotes tumor formation. Insights into a mechanistic understanding of cellular senescence and SASP provide the basis for targeted therapies, such as senolytics(definition), which aim to eliminate senescent cells, or SASP inhibitors, which would eliminate the tumor-promoting effects of senescence. These therapeutic interventions offer significant clinical implications for treating cancer and healthy aging.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1007/s10238-025-01564-8
- Canonical
- link ↗
- Fetched
- 2026-10-05 MST
Cite this
APA
Alavimanesh, S., Jazi, N.N., Choubani, M., Saeidi, F., Afkhami, H., Yarahmadi, A., Ronaghi, H., Khani, P., & Modarressi, M.H. (2025). Cellular senescence in the tumor with a bone niche microenvironment: friend or foe?. <em>Clinical and Experimental Medicine</em>. https://doi.org/10.1007/s10238-025-01564-8
Vancouver
Alavimanesh S, Jazi NN, Choubani M, Saeidi F, Afkhami H, Yarahmadi A, et al. Cellular senescence in the tumor with a bone niche microenvironment: friend or foe?. Clinical and Experimental Medicine. 2025. doi:10.1007/s10238-025-01564-8.
BibTeX
@article{sajad2025Cellul,
title = {Cellular senescence in the tumor with a bone niche microenvironment: friend or foe?},
author = {Sajad Alavimanesh and Negar Nayerain Jazi and Maedeh Choubani and Farzane Saeidi and Hamed Afkhami and Aref Yarahmadi and Hossein Ronaghi and Pouria Khani and Mohammad Hossein Modarressi},
journal = {Clinical and Experimental Medicine},
year = {2025},
doi = {10.1007/s10238-025-01564-8},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Biomolecules 2025
Open access · CC-BY
Targeting Senescence: A Review of Senolytics and Senomorphics in Anti-Aging Interventions
Thermal Medicine 2019
Open access · OA
Stress-induced Cellular Senescence Contributes to Chronic Inflammation and Cancer Progression
International Journal of Molecular Sciences 2019
Open access · CC-BY
Exosomes as Emerging Pro-Tumorigenic Mediators of the Senescence-Associated Secretory Phenotype
Drug design, development and therapy 2025
Open access · OA
Targeting Cellular Senescence for Healthy Aging: Advances in Senolytics and Senomorphics.
The Journal of Biochemistry 2024
Open access · CC-BY
Cellular senescence: mechanisms and relevance to cancer and aging
Journal of the European Academy of Dermatology and Venereology 2024
Open access · OA